These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1968167)

  • 41. Reperfusion, patency and reocclusion with anistreplase (APSAC) in acute myocardial infarction.
    Anderson JL
    Am J Cardiol; 1989 Jul; 64(2):12A-17A; discussion 24A-26A. PubMed ID: 2662737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction.
    Been M; de Bono DP; Muir AL; Boulton FE; Fears R; Standring R; Ferres H
    Int J Cardiol; 1986 Apr; 11(1):53-61. PubMed ID: 3514485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study.
    Renkin J; Beys CC; Lavenne-Pardonge E; Pintens H; Col J
    Drugs; 1987; 33 Suppl 3():253-60. PubMed ID: 3315603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction.
    Marder VJ; Rothbard RL; Fitzpatrick PG; Francis CW; Norry EC
    Drugs; 1987; 33 Suppl 3():124-32. PubMed ID: 3315577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous bolus application of streptokinase and of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Clinical and haemostaseological findings.
    Hellstern P; Doenecke P; Köhler M; Schwerdt H; Ozbek C; Miyashita C; Bette L; Wenzel E
    Drugs; 1987; 33 Suppl 3():183-5. PubMed ID: 3315589
    [No Abstract]   [Full Text] [Related]  

  • 46. Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Kasper W; Meinertz T; Wollschläger H; Bonzel T; Chen C; Hofmann T; Zeiher A; Drexler H; Just H
    Drugs; 1987; 33 Suppl 3():112-6. PubMed ID: 3315575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic effects of anisoylated plasminogen streptokinase activator complex and streptokinase therapy in acute myocardial infarction. Coagulation aspects of the Dutch Invasive Reperfusion Study.
    Hoffmann JJ; Bonnier JJ; de Swart JB; Custers P; Vijgen M
    Drugs; 1987; 33 Suppl 3():242-6. PubMed ID: 3315602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prehospital administration of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Castaigne AD; Duval AM; Dubois-Rande JL; Herve C; Jan F; Louvard Y
    Drugs; 1987; 33 Suppl 3():231-4. PubMed ID: 3315600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fibrinolysis therapy using APSAC in acute myocardial infarct].
    Hochrein H
    Dtsch Med Wochenschr; 1990 Jun; 115(25):999. PubMed ID: 2193790
    [No Abstract]   [Full Text] [Related]  

  • 51. Intracoronary streptokinase versus intravenous anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarction.
    Kaspar L; Karnik R; Sehnal E; Zajicek P; Ziegler B; Slany J
    Drugs; 1987; 33 Suppl 3():179-82. PubMed ID: 3315588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and tolerance data from the Belgian multicentre study of anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction.
    Bossaert LL
    Drugs; 1987; 33 Suppl 3():287-92. PubMed ID: 3315610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological study of intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Samama M; Conard J; Verdy E; van Dreden P; Nguyen G; Combrisson A; Acar J
    Drugs; 1987; 33 Suppl 3():268-74. PubMed ID: 3315605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary safety and tolerance data obtained in the comparative study of anisoylated plasminogen streptokinase activator complex versus heparin.
    Croydon EA
    Drugs; 1987; 33 Suppl 3():293-6. PubMed ID: 3315611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limitation of myocardial infarct size and preservation of left ventricular function by early administration of APSAC in myocardial infarction.
    Bassand JP; Machecourt J; Cassagnes J; Lusson JR; Borel E; Schiele F
    Am J Cardiol; 1989 Jul; 64(2):18A-23A; discussion 24A-26A. PubMed ID: 2662738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative tolerance and complications in a multicentre trial of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Rothbard RL
    Drugs; 1987; 33 Suppl 3():276-8. PubMed ID: 3315606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of reperfusion on electrocardiographic and enzymatic infarct size: results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction.
    Hackworthy RA; Sorensen SG; Fitzpatrick PG; Barry WH; Menlove RL; Rothbard RL; Anderson JL
    Am Heart J; 1988 Oct; 116(4):903-14. PubMed ID: 3051985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safe use of thrombolysis in the elderly.
    Wittry MD; Thornton TA; Chaitman BR
    Geriatrics; 1989 Nov; 44(11):28-30, 33-6. PubMed ID: 2509296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Hillis WS; Hornung RS; Hogg KJ; Hockings N; Burns JM; Dunn FG
    Drugs; 1987; 33 Suppl 3():117-23. PubMed ID: 3315576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Bossaert LL; Demey HE; Colemont LJ; Beaucourt L; Fierens H; Dirix L; Pintens H
    Crit Care Med; 1988 Sep; 16(9):823-30. PubMed ID: 3042284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.